Lumosa Therapeutics (Lumosa; 6535.TWO) today announced positive results from its Phase 2b clinical trial (LT3001-202) evaluating LT3001 (intravenous Odatroltide) in patients with acute ischemic stroke.
The council unites leading scientists, clinicians, and advocates to ensure that cutting-edge research and lived experience together shape the future of mental health care.
Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center (UTHSC) are proud to announce the appointment of Jason S. Frischer, MD, as Surgeon-in-Chief and Chief of Pediatric Surgery.
This Grant will Advance the Company’s Preclinical Research to Demonstrate an Improvement to the Current Standard of Care for Treating Vertebral Compression Fractures
Changes are coming to a special visa that allows skilled foreign workers into the U.S., as a $100,000 fee introduced by President Donald Trump is being implemented.
The NCPDP Foundation is pleased to announce the successful completion of a study conducted by the University of Tennessee Health Science Center, College of Pharmacy.
Ivy Fertility, a nationally recognized network of fertility clinics, is proud to support a new Reproductive Endocrinology and Infertility fellowship program initiated by Fertility Associates of Memphis within the Graduate Medical Education program at the University of Tennessee Health Sciences Center.
Qventus’ Surgical Growth Solution Modernizes Operations and Alleviates the Administrative Burden on Care Teams for Leading Tennessee-Based Healthcare System
